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Enucleation and reconstruction of interferon-producing cells
(L celis/Sendai virus)
D. C. BURKE* AND G. VEOMETTt
Department of Molecular, Cellular and Developmental Biology, University of Colorado, Boulder, Colorado 80309
Communicated by David M. Prescott, April 6,1977
ABSTRACT Enucleation of L cells leads to loss of the ca-
pacity to produce interferon, showing that the cell nucleus is
essential for interferon formation. However, when the cells were
enucleated while interferon formation was proceeding, the
cytoplasts were capable of continuing to synthesize interferon
by a process shown to be protein synthesis, showing that the
interferon messenger RNA leaves the nucleus after synthesis.
Reconstructed cells were obtained by Sendai virus fusion of
karyoplasts and cytoplasts. Such reconstructed cells were ca-
pable of producing at least as much interferon (43 interferon
units/104 nucleated cells) as control cells (31 interferon units/104
nucleated cells).
Nearly all mammalian and avian cells produce interferon in
response to viruses or double-stranded polyribonucleotides. The
process, which is only partially understood, involves activation
of a cellular interferon gene, followed by transcription and
translation of the mRNA. The scheme, initially formulated as
a result of work with metabolic inhibitors (1), has recently been
strengthened by two findings: (i) that specific chromosomes are
essential for interferon production, presumably because they
carry the structural gene for interferon (2, 3), and (if) that the
interferon mRNA, present in induced cells, can be translated'
in heterologous tissue culture cells, Xenopus oocytes, and
cell-free systems (4-7). Little is known about the detailed
mechanisms involved, particularly the way in which treatment
with virus or polyribonucleotide activates the cellular gene
system for interferon. Nor is it known how the process is mod-
ulated by priming with interferon (8), by superinduction with
metabolic inhibitors (9), or by repeated treatment of the cells
with inducer-the hyporesponsive process (10). All these pro-
cesses are likely to involve subtle nuclear-cytoplasmic inter-
actions, and the enucleation technique using centrifugation in
the presence of cytochalasin B (CB) (11) provides a powerful
tool for investigating the roles of nucleus and cytoplasm in the
control of cellular processes. In particular, it is now possible to
reconstruct viable cells by fusing cytoplasts (enucleated cells)
to karyoplasts (nucleated cellular fragments) with Sendai virus
(12), the cell fragments being derived from the identical or from
genetically distinguishable cell parents (13). We have used the
techniques of cell enucleation and reconstruction to study the
role of the nucleus during interferon formation and to prepare
reconstructed cells capable of making interferon.
MATERIALS AND METHODS
Cells and Viruses. Mouse L cells were grown in Eagle's
minimum essential medium supplemented with 10% fetal calf
serum (FCS). They were shown to be mycoplasma-free by the
uridine phosphorylase method (14). Newcastle disease virus
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(NDV) (strain B1) was received from T. C. Merigan, Division
of Infectious Diseases, Stanford University, and was grown in
fertile hen eggs. Ultraviolet-irradiated NDV (UV-NDV) was
prepared by irradiating 1-ml aliquots of virus with 720 ergs (72j4)/mm2 from a General Electric germicidal lamp (G30TS)
after overnight dialysis of the virus against phosphate-buffered
saline. Infectivity, as measured by plaque assay in primary chick
embryo cells (15), fell from 1.1 X 109 plaque-forming units
(PFU)/ml to 7 X 104 PFU/ml as a result of this treatment. NDV
(strain La Sota), received from G. Poste, Roswell Park Memorial
Institute, Buffalo, NY, and Sendai virus, received from D.
Kingsbury, -St. Jude Children's Research Hospital, Memphis,
TN, were also grown in fertile hen eggs. These viruses were
inactivated by ultraviolet light as described above except that
the Sendai virus receivedc7200 ergs (720 uJ)/mm2. Since neither
of these viruses formed plaques in chick or L cells,, they were
titrated by a hemagglutination assay using serial 1:2 dilutions
of virus with an equal volume of 0.5% chick embryo red cells.
Semliki Forest virus was grown in chick embryo cells in sus-
pension as described (16).
Preparation and Assay of Interferon. Interferon was in-
duced either with NDV or UV-NDV by treatment of L cells
with virus for 1 hr at 370 followed by washing with minimum
essential medium plus 2% FCS and incubation in the same
medium at 37° before the fluids were harvested 24 hr later.
Samples for interferon assay were dialyzed for 5 days against
a pH 2 buffer to destroy virus before overnight dialysis against
Earle's buffered salt solution and assay.
Interferon was assayed by a micromodification of the viral
RNA reduction assay (17) in which serial 0.5 logio dilutions of
interferon were incubated overnight with a monolayer of 105
L cells in small glass vials before challenge with Semliki Forest
virus (1 X 107 PFU) in the presence of actinomycin D (1 ,g/ml)
and addition of [3H]uridine (final, 1 ACi/ml) 2 hr later. Incor-
poration of isotope was terminated 3 hr later by withdrawal of
fluids, washing with ice-cold 0.9% NaCI, ice-cold 5% trichlo-
roacetic acid (twice), and 95% EtOH. The dried cell sheets were
dissolved in 100 Al of Soluene (Packard Instrument Co. Ltd.,)(diluted 1:3 with toluene) before addition of 2 ml of scintillation
fluid and measurement of radioactivity. The interferon titer
was defined as the reciprocal of the dilution causing a 50%
depression in virus RNA synthesis. The results are expressed in
international reference research units; all assays contained an
internal standard.
Cell Enucleation and Reconstruction. Cells were enu-
Abbreviations: FCS, fetal calf serum; CB, cytochalasin B; NDV,
Newcastle disease virus; UV-NDV, ultraviolet-inactivated Newcastle
disease virus; PFU, plaque-forming unit; HAU, hemagglutinating
unit.
e On leave from the Department of Biological Sciences, University of
Warwick, Coventry CV4 7AL, England.
tPresent address: University of Nebraska-Lincoln, Lincoln, NE
68588.
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FIG. 1. Total protein content (Top) and radioactive incorporation
of [3H]leucine (Middle)- and [14C]uridine (Bottom) into acid-insoluble
material of whole cells and cytoplasts at different times after enu-
cleation. L cells (8 X 105/25-cm2 flask) were pulsed for 1 hr with a
mixture of isotopes and then processed as described in Materials and
Methods. The radioactive incorporation into cytoplasts has been
corrected for any loss in cell numbers during enucleation.
cleated in 25-cm2 flasks by method A described by Veomett et
al. (18). They were reconstructed by adding excess karyoplasts
to a monolayer of cytoplasts and using Sendai virus to cause
fusion. The karyoplast pellet in each 25-cm2 flask was carefully
resuspended in a small volume of the growth medium con-
taiing CB, the pooled karyoplasts were centrifuged at 500 rpm
for 7 min, and the pellet was washed twice with balanced salt
solution before resuspension in balanced salt solution (0.6 ml
per fusion reaction). Meantime, the cytoplast monolayers were
allowed to recover from the effects of CB treatment by incu-
bation in minimum essential medium + 10% FCS for 30-45
min at 370. The medium was removed, ice-cold balanced salt
solution was added (2.5 ml per flask), and the flask was put at
40 for 20 min.
The balanced salt solution was then removed and 1.0 ml of
UV-inactivated Sendai virus in the salt solution was added [200
hemagglutinating units (HAU)/mlj. The flasks were placed at
40 for a further 20 min. Control flasks were treated with an
equal amount of Sendai virus that had been treated with 0.5%
f3-propiolactone, so that it no longer caused cell fusion. After
this, the virus was removed and the monolayers were washed
twice with ice-cold balanced salt solution (5 ml per flask) with
vigorous shaking of the flask with each wash. The karyoplasts
(0.6 ml of the washed suspension containing karyoplasts from
12 flasks) or control fluid (balanced salt solution) was then added
and the flasks were rocked and put at 40 for a further 20 min,
the flasks being rocked every 5 min. Then 2.2 ml per flask of
minimum essential medium plus 10% FCS warmed to 450 was
added, and the flasks were incubated at 370 for 45 min. The
flasks were then shaken vigorously, the medium was removed,
and the monolayers were washed twice with minimum essential
medium + 10% FCS at 370 (5 ml per flask) with vigorous
shaking during each wash. Finally, 4 ml of medium plus 0.2 ml
of NDV (strain La Sota, 2500 HAU/ml) was added and the
flasks were incubated overnight at 370. The fluids were re-
moved, dialyzed at pH 2 for 5 days, and assayed for interferon.
The cell sheets were stained with crystal violet, and the per-
centage of nucleated cells and number of cells per flask were
estimated by counting with a microscope at a magnification of
X100.
Incorporation of Radioactive Precursors into Whole Cells
and Cytoplasts. Cells, or cytoplasts, were incubated with the
precursor for the times stated in the text before removal of
medium. They were washed three times with ice-cold 0.9%
saline, three times with ice-cold 5% trichloroacetic acid, and
once with 95% ethanol. The cell sheets were dissolved in 0.25
M NaOH before neutralization, addition of scintillation fluid,
and measurement of radioactivity. The protein content of the
different preparations was determined according to Lowry et
al. (19), with bovine serum albumin as standard.
RESULTS
Cell Enucleation and Characterization of Cytoplasts.
Enucleation of L cells by centrifugation in the presence of 10
,qg of CB per ml gave 99.6% enucleation (average of four de-
terminations, range 99.4-99.75%), as judged by counting of
stained monolayers after enucleation, or 98.1% enucleation, as
judged by labeling the cell sheets with [3H]thymidine for 2 hr
before enucleation, followed by determination of radioactivity
before and after enucleation. Trypsinization and counting of
the cells before and after enucleation showed that cell recovery
was 91% (average of four determinations, range 87-94%). The
synthetic activity of the cytoplasts was measured by comparison
of the incorporation of [3H]thymidine, [14C]uridine, and
[3H]leucine into acid-insoluble material in cytoplasts and in
whole cells. The results (Fig. 1) showed that slightly over half
the cell protein was lost during enucleation and that the cyto-
plasts had only about 25% of the protein synthetic activity of
the whole cells, but that this activity was only slightly dimin-
ished after 10 hr of incubation in growth medium. The cyto-
plasts were effectively unable to incorporate [14C]uridine or
[3H]thymidine (data not shown). Measurement of the trichlo-
roacetic acid-soluble pools of the cytoplasts showed that they
decreased to 68% of controls ([3H]leucine) or to 50% of controls
([14C]uridine). Correction of the protein synthetic activity of
the cytoplasts for this reduction in the pool size raised the ac-
tivity to 37% of the controls.
Production of Interferon in Whole Cells and Cytoplasts.
Infection of L cells with NDV (B1 strain) led to limited virus
multiplication; the product consisted mainly of noninfective
particles, as shown by the lower PFU/HAU ratio (log1o 4.45)
of the product compared with that of egg-grown virus (logio
5.74). Interferon was produced in whole cells in high yield (Fig.
2 left), but there was also a virus-mediated cytopathic effect,
first visible at 14 hr after infection.
Since we did not wish to study interferon production in cells,
or cytoplasts, showing visible cytopathic effects, we used UV-
NDV, which produced a slightly lower yield of interferon with
very similar kinetics without any virus multiplication (Fig. 2
right). When cells were enucleated either immediately before
or immediately after infection with NDV or UV-NDV (strain
B1), no interferon was formed (Table 1), showing that the nu-
cleus was essential for interferon formation. Enucleation of the
cells was responsible for the reduction in interferon yield since
neither centrifugation of the cells in the absence of CB nor
treatment of the cells with CB in the absence of centrifugation
affected the yield of interferon (data not shown).
Enucleation during Interferon Production. Experiments
with actinomycin, which inhibits interferon production because
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FIG. 2. Production of interferon by (Left) NDV and (Right) UV-NDV in L Cells. e, Extracellular; 0, intracellular.
of its inhibitory effect on transcription, have shown that when
actinomycin was added at increasingly later periods after the
induction of interferon synthesis, it had a decreasingly inhibi-
tory effect on subsequent interferon production. This has been
interpreted as being due to the formation of a stable mRNA for
interferon, although other interpretations are possible (see ref.
1). The enucleation technique provided a direct way to examine
the role of the cell nucleus at different times during interferon
production, since enucleation was effectively complete and
produced cytoplasts that continued protein synthesis for at least
10 hr. In addition, the yield of interferon was high enough to
enable the rate of interferon formation to be measured over
quite short periods.
Cells were treated with UV-NDV and enucleated at different
times thereafter, and the subsequent rate of interferon pro-
duction was followed. Parallel, nonenucleated cultures were
treated with 1 ug of actinomycin per ml for 1 hr at the same
time as the enucleation (a treatment shown in separate exper-
iments to completely inhibit interferon production when the
actinomycin was added immediately after virus infection),
while other untreated cultures served as controls. The results
(Fig. 3) showed that both cytoplasts and actinomycin-treated
cells continued to produce interferon for several hours after
enucleation or actinomycin treatment. Comparison of the re-
sults obtained at the three different times shows that enuclea-
tion, and to a lesser extent actinomycin treatment, at 8 hr after
infection caused a reduction in the rate of interferon produc-
tion. However, the effect of enucleation was less at 10 hr and
Table 1. Effect of enucleation on interferon formation
Interferon yield,
Exp. Treatment loglo units
1 NDV-infected control 3.95
Enucleated, then infected 0.90 (0.1%)
Infected, then enucleated 1.45 (0.3%)
2 UV-NDV-infected control 3.50
Infected, then enucleated 1.85 (2.2%)
much less at 13 hr after infection. The decreasing effect of
enucleation or actinomycin treatment on interferon production
with longer times is probably due to the effective completion
of the synthesis of the interferon messenger RNA by 13 hr after
infection. This interpretation was confirmed by a direct ex-
periment (Table 2) in which the effect of actinomycin on the
yield of interferon between the time of addition and 24 hr was
measured. The results (Fig. 2) showed that 10, 20, and 60% of
the control amount of interferon was produced when actino-
mycin was added at 8, 10, and 13 hr, respectively, after in-
duction. At the two earlier times the effect of enucleation on
the rate of production was more marked that that of actino-
mycin. This was probably because, at these times, more of the
interferon messenger than at later times is being processed in
the nucleus or is perinuclear and is lost from the cell in the
karyoplast. It is also clear from the figure that the rate of in-
terferon production first rises, as would be expected early in the
production cycle, and then falls, and that the rate of fall is very
similar in control, actinomycin-treated, and enucleated cells.
Two other experiments showed that interferon production
in cytoplasts was the result of protein synthesis. In the first,
cycloheximide (100 tig/ml) was added to control, enucleated,
and actinomycin-treated cultures immediately after treatment
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FIG. 3. The rate of interferon formation when cells infected
with UV-NDV were enucleated at 8, 10, and 13 hr after infection (A&),
or treated with actinomycin D (1 gg/ml) for 1 hr at the same time (0)
compared with controls (0).
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Table 2. Effect of addition of actinomycin on interferon (IF)
formation in L cells
Yield of IF between time
point and 24 hr*
Time, Yield of IF at In presence of
hr time point* In control actinomycin
0 0 3.90 <1.0
2 0.5 3.90 1.25
4 1.25 4.15 2.15
6 1.70 3.95 2.75
8 2.60 3.95 2.70
10 3.20 3.65 2.90
12 3.45 3.75 3.20
14 3.75 3.70 3.65
Actinomycin (1 ,g/ml) in minimum essential medium + 2% FCS
was added at the times stated.
* In loglo units.
and the rate of interferon production was compared to that in
parallel cultures not treated with cycloheximide. Table 3 shows
that cycloheximide decreased the rate of interferon production
in all three cultures at very similar rates, indicating that protein
synthesis was required in each case. The lack of effect of cy-
cloheximide during the first hour of treatment may be due to
the time taken for the completed polypeptide to be glycosy-
lated, since it is unlikely that cycloheximide will have any effect
on the glycosylation process. A second experiment was designed
to test the possibility that the cytoplasts did not synthesize in-
terferon but merely released material present in a large internal
pool. Measurement of the intracellular levels of interferon in
control, enucleated, and actinomycin-treated cells showed that
the levels were low (6-10% of the extracellular levels), and that
this figure was very similar for all three sets of cultures at three
different times after enucleation or actinomycin treatment
(data not shown).
Reconstruction of Interferon-Producing Cells. Sendai
virus-induced fusion of cytoplasts and karyoplasts leads to the
formation of nucleated cells capable of cell division (12). In
order to use this technique for the study of nuclear-cytoplasmic
relationships in interferon-producing cells it was necessary to
obtain a high yield of reconstructed cells and to reduce, as far
as possible, whole cell contamination of both cytoplasts and
karyoplasts. Yields of reconstructed cells varying from 3 to 8%
could be obtained by careful attention to the details of the fusion
procedure. Photomicrographs of marked microscopic fields
confirmed that enucleated cells had fused with karyoplasts to
produce nucleated cells. Whole cell contamination of the cy-
toplasts was estimated by measuring the yield of interferon from
cytoplasts that had not been treated with karyoplasts and
comparing the yield with that from whole cells. It was assumed
that any interferon produced was due to remaining whole cells.
Whole cell contamination of the karyoplasts was measured by
adding an overinactivated preparation of Sendai virus that was
incapable of inducing fusion to the cytoplast/karyoplast mix-
ture and measuring the yield of interferon. Since any whole cells
present in the karyoplast preparation would still attach to the
plastic support and yield interferon, any increase of interferon
yield compared with that of cytoplasts alone was due to the
presence of nucleated cells in the karyoplasts. Table 4 shows the
results of four consecutive reconstruction experiments. Com-
parison of column 7 with columns 3 and 5 showed that fusion
of karyoplasts and cytoplasts with Sendai virus led to an ap-
proximately 10-fold increase in the number of nucleated cells,
while comparison of column 8 with columns 4 and 6 showed
Table 3. Effect of cycloheximide (100 Ag/ml) on interferon
production in enucleated, actinomycin-treated, and control cells
Interferon yields, loglo units
Time, Cyclo- Actinomycin-
hr heximide Enucleated treated Control
11-12 - 2.15 2.80 3.05
+ 1.95 2.90 3.15
12-14 - 2.75 3.60 3.75
+ 1.10 1.85 2.15
14-16 - 2.40 3.75 3.50
+ 0.30 1.60 1.55
The cells were enucleated or treated with actinomycin at 10 hr after
infection, and cycloheximide was added immediately afterwards.
Interferon samples were then harvested at the times shown.
yields. Calculation of the interferon yield per viable cell gave
a figure of 31 units/104 cells (range 23-39) for the control and
43 units/104 cells (range 30-59) for the reconstructed cells,
showing that the reconstructed cells produced at least as much
interferon per cell as the original cells. It was not possible to
determine whether karyoplasts as such were capable of inter-
feron production since they rapidly lost their integrity on in-
cubation at 370, becoming readily permeable to trypan blue.
DISCUSSION
We have shown that enucleation of L cells leads to loss of the
capacity to produce interferon. A similar result was obtained
when human cells were enucleated before treatment with
poly(rI-rC) (data not shown). The failure of enucleated cells to
produce interferon shows that the cell nucleus is essential for
interferon production. This confirms a conclusion reached as
a result of the study of mouse-human hybrid cells (2, 3) and
excludes, for example, the possible hypothesis that interferon
is coded by a mitochondrial gene.
However, when the cells were enucleated while interferon
formation was proceeding, the resulting cytoplasts were capable
of continuing to synthesize interferon for several hours by a
process that was shown to be protein synthesis. This is only the
second report of continued synthesis of a cell-coded product
in cytoplasts (20), and clearly demonstrates that the interferon
mRNA is in the cytoplasm. Comparison of the effect of acti-
nomycin treatment with that of enucleation at 8 hr after in-
duction (a time when interferon production has just started)
showed that enucleated cells subsequently produced interferon
at a lower rate than did actinomycin-treated cells. However,
at later times the difference was much smaller. The probable
explanation of the difference is that the nuclear and perinuclear
cytoplasmic material in the karyoplast contains more interferon
mRNA at 8 hr after induction than at later times, suggesting
movement of the mRNA away from the immediate nuclear
region as messenger synthesis slows down. Comparison of the
change in the rate of interferon production in enucleated cells
with that in actinomycin-treated and in control cells on con-
tinued incubation showed that the rate decreased in each case
with similar kinetics. The most likely explanation of this is that
the interferon mRNA breaks down at similar rates, although
whether this is a process that is specific for interferon mRNA
and, in particular, whether this breakdown is the explanation
of the hyporesponsive effect (10) is not known.
Reconstructed cells could be obtained by Sendai virus-in-
duced fusion of karyoplasts and cytoplasts, and by careful at-
tention to detail it was possible to raise the yield to 3-8%. This
level was essential in order to distinguish interferon production
due to reconstructed cells from that due to whole cell contam-
that this was accompanied by a similar increase in interferon ination of cytoplasts and karyoplasts.
Proc. Nati. Acad. Sci. USA 74 (1977)
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Table. 4. Reconstruction of interferon (IF)-producing cells
Reconstruction control
Enucleated cells (fusion using over-
Whole cells (cytoplasts) inactivated virus) Reconstructed cells
No. of No. of No.'of
No. of nucleated nucleated nucleated
cells IF yield* cells IF yield* cells IF yield* cells IF yield*
Exp. (1) (2) (3) (4) (5) (6) (7) (8)
1 4.0 X16 4.20 1X0"1.80 1.2 X 104 2.30 2.7 X i05 2.95
(100) (100) (0.25) (0.4) (0.3) (1.0) (6.5) (5.7)
2 1.9 X 106 3.65 1.1 X 10" 1.00 1.3 X 104 1.70 1.5 X i05 2.95
(100) (100) (0.6) (0.22) (0.8) (1.1) (8) (20)
3 2.6X106 3.90 1.3X104 0 2.1 X104 1.50 9.4X 104 *2.45
(100) (100) (0.5) (0) (0.8) (0.4) (3.6) (3.6)
4 1.8 X 106 3.75 0.5 X 10" 0.85 1 X 104 1.65 1.5 X i05 2.85
(100) (100) (0.28) (0.1) (0.55) (0.8) (8.3) (12.6)
Values are given per flask. The numbers in parentheses are the percentage of the respective whole cell control.
*In logl,, units.
The yield of interferon per reconstructed cell was almost the
same as that from the original culture, showing that cytoplasts,
which themselves cannot undergo induction of interferon
synthesis, can give normal yield after fusion with karyoplasts.
The production of interferon is in fact a'very sensitive proce-
dure for monitoring production of a specific protein because
of the very high specific activity [at least 2 X 108 units/mg of
protein '(21)] of interferon. The way is now open to prepare
reconstructed cells from karyoplasts and cytoplasts from cells
of a single species that have been treated in different ways (e.g.,
primed with interferon) or from different species to produce
hybrid reconstructed cells.
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